Oxford Immunotec, Inc. announces that the National Acquisition Center of the Department of Veterans Affairs has awarded a Federal Supply Schedule contract to Oxford Diagnostic Laboratories for T-SPOT.TB testing. This contract will be effective from Nov. 1, 2011 through Oct. 31, 2016.
Oxford Diagnostic Laboratories, a division of Oxford Immunotec, Inc., is the only national TB testing service exclusively dedicated to the T-SPOT.TB test. The laboratory, which is located in Marlborough, Mass., provides TB testing services to hundreds of physicians and healthcare institutions throughout the US.
The T-SPOT.TB test is a blood test, also known as an Interferon Gamma Release Assay (IGRA), used to test for tuberculosis (TB) infection. The introduction of IGRAs provides healthcare institutions with a key tool in eradicating TB in the United States. The Centers for Disease Control and Prevention (CDC) recommends that IGRAs can be used in all situations where the tuberculin skin test (TST) is currently used.
The T-SPOT.TB test received premarket approval from the Food and Drug Administration (FDA) in July 2008. The test is backed by the clinical evidence of over 200 peer-reviewed publications, and is the only TB screening test with sensitivity and specificity exceeding 95 percent in FDA pivotal trials. The T-SPOT.TB test has become widely utilized in hundreds of hospitals, medical practices and public health facilities throughout the United States.
Government facilities depend on simple, accurate screening for their healthcare workers, patients and military personnel for this important transmissible disease. IGRAs, such as the T-SPOT.TB test, address the well-documented limitations of the TST, such as false positive test results, failure of individuals to return for the reading of the test result and poor reliability in individuals with weakened immune systems. The awarding of this contract ensures that all government facilities will now have immediate access to a more accurate and reliable test.
Commenting on the contract award, Dr. Peter Wrighton-Smith, CEO of Oxford Immunotec, says, The awarding of this contract to Oxford Diagnostic Laboratories for T-SPOT.TB testing services will provide easy access to the T-SPOT.TB test to all government facilities. I am pleased that the National Acquisition Center believes that it is important that their entities have access to the T-SPOT.TB test.
Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.